Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascau

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 28, 2022
Clinical feasibility of combining intraoperative electron radiation therapy with minimally invasive surgery: a potential for electron-FLASH clinical developmentFelipe Ángel Calvo Manuel, Javier Serrano, Claudio Solé, et al.
Healthcare Technology Letters|December 25, 2024
AR-assisted surgery: Precision placement of patient specific hip implants based on 3D printed PSIsAmaia Iribar-Zabala, Tanya Fernández-Fernández, Javier Orozco-Martínez, et al.
Frontiers in Oncology|February 6, 2023
Corrigendum: Practice-oriented solutions integrating intraoperative electron irradiation and personalized proton therapy for recurrent or unresectable cancers: Proof of concept and potential for dual FLASH effectFelipe A Calvo, Adriana Ayestaran, Javier Serrano, et al.
Chemmedchem|January 13, 2018
Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of PsoriasisGilles Ouvry, Nicolas Atrux-Tallau, Franck Bihl, et al.
The British Journal of Dermatology|July 6, 2018
Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifaroteneJ Aubert, D Piwnica, B Bertino, et al.
The Lancet. Neurology|January 21, 2023
Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2-3 trialWolfgang Köhler, Marc Engelen, Florian Eichler, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2016
Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonistsGilles Ouvry, Claire Bouix-Peter, Fabrice Ciesielski, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Impact of Minor Structural Modifications on Properties of a Series of mTOR InhibitorsGilles Ouvry, Laurence Clary, Loïc Tomas, et al.
Translational Psychiatry|January 24, 2013
Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophreniaL Urigüen, I Gil-Pisa, E Munarriz-Cuezva, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2017
Identification of novel TACE inhibitors compatible with topical applicationGilles Ouvry, Yaël Berton, Yushma Bhurruth-Alcor, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 28, 2022
Clinical feasibility of combining intraoperative electron radiation therapy with minimally invasive surgery: a potential for electron-FLASH clinical developmentFelipe Ángel Calvo Manuel, Javier Serrano, Claudio Solé, et al.
Healthcare Technology Letters|December 25, 2024
AR-assisted surgery: Precision placement of patient specific hip implants based on 3D printed PSIsAmaia Iribar-Zabala, Tanya Fernández-Fernández, Javier Orozco-Martínez, et al.
Frontiers in Oncology|February 6, 2023
Corrigendum: Practice-oriented solutions integrating intraoperative electron irradiation and personalized proton therapy for recurrent or unresectable cancers: Proof of concept and potential for dual FLASH effectFelipe A Calvo, Adriana Ayestaran, Javier Serrano, et al.
Chemmedchem|January 13, 2018
Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of PsoriasisGilles Ouvry, Nicolas Atrux-Tallau, Franck Bihl, et al.
The British Journal of Dermatology|July 6, 2018
Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifaroteneJ Aubert, D Piwnica, B Bertino, et al.
The Lancet. Neurology|January 21, 2023
Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2-3 trialWolfgang Köhler, Marc Engelen, Florian Eichler, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2016
Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonistsGilles Ouvry, Claire Bouix-Peter, Fabrice Ciesielski, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Impact of Minor Structural Modifications on Properties of a Series of mTOR InhibitorsGilles Ouvry, Laurence Clary, Loïc Tomas, et al.
Translational Psychiatry|January 24, 2013
Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophreniaL Urigüen, I Gil-Pisa, E Munarriz-Cuezva, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2017
Identification of novel TACE inhibitors compatible with topical applicationGilles Ouvry, Yaël Berton, Yushma Bhurruth-Alcor, et al.
Pageof 15